Published in Medicine (Baltimore) on September 01, 1998
Bronchiolitis obliterans organizing pneumonia: pathogenesis, clinical features, imaging and therapy review. Ann Thorac Med (2008) 1.25
Eosinophilic pneumonias. Clin Microbiol Rev (2012) 1.20
Idiopathic chronic eosinophilic pneumonia. Orphanet J Rare Dis (2006) 0.98
Chronic eosinophilic pneumonia in a 13-year-old child. Eur J Pediatr (2008) 0.86
Chronic eosinophilic pneumonia with persistent decreased diffusing capacity for carbon monoxide. BMJ Case Rep (2013) 0.77
Chronic eosinophilic pneumonia presenting with ipsilateral pleural effusion: a case report. J Med Case Rep (2016) 0.75
Idiopathic acute eosinophilic pneumonia: A retrospective case series and review of the literature. Respir Med Case Rep (2013) 0.75
Unusual presentation of chronic eosinophilic pneumonia with "reversed halo sign": a case report. Iran J Radiol (2014) 0.75
Idiopathic eosinophilic pneumonia in children: the French experience. Orphanet J Rare Dis (2014) 0.75
Pulmonary Eosinophilia Following Infliximab Treatment for Crohn's Disease. Gastroenterol Hepatol (N Y) (2006) 0.75
Chronic eosinophilic pneumonia: a paediatric case. BMJ Case Rep (2013) 0.75
A pneumonia that will not go away. Can Respir J (2014) 0.75
Diagnosis in just over a minute: a case of chronic eosinophilic pneumonia. J Gen Intern Med (2013) 0.75
Significance of fractional exhaled nitric oxide in chronic eosinophilic pneumonia: a retrospective cohort study. BMC Pulm Med (2014) 0.75
Chronic eosinophilic pneumonia: Adjunctive therapy with inhaled steroids. Respir Med Case Rep (2017) 0.75
ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis (1999) 3.69
A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum (1997) 3.62
European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J (2010) 2.86
Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia. Int Arch Allergy Appl Immunol (1983) 2.17
Tracheobronchopathia osteochondroplastica: a study of 41 patients. Medicine (Baltimore) (2001) 2.11
Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore) (1999) 2.11
Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med (1986) 2.03
Primary pulmonary lymphomas. A clinical study of 70 cases in nonimmunocompromised patients. Chest (1993) 2.01
Diagnostic efficiency of endotracheal aspirates with quantitative bacterial cultures in intubated patients with suspected pneumonia. Comparison with the protected specimen brush. Am Rev Respir Dis (1993) 1.94
Exogenous lipid pneumonia: a retrospective multicentre study of 44 cases in France. Eur Respir J (1996) 1.83
Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med (1999) 1.77
Primary cardiac sarcomas: an immunohistochemical and grading study with long-term follow-up of 24 cases. Histopathology (1999) 1.75
ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem (1996) 1.63
Latent pulmonary involvement in Crohn's disease: biological, functional, bronchoalveolar lavage and scintigraphic studies. Gut (1986) 1.63
Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis (1992) 1.63
[Opportunistic infections and sarcoidosis]. Rev Mal Respir (2004) 1.58
[Treatment of pulmonary lymphangioleiomyomatosis using a GnRH agonist]. Rev Mal Respir (1996) 1.48
High-dose and low-dose systemic corticosteroids are equally efficient in acute severe asthma. Eur Respir J (1995) 1.48
Increased secretion of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J Allergy Clin Immunol (1991) 1.46
Migratory organizing pneumonitis "primed" by radiation therapy. Eur Respir J (1995) 1.45
Involvement of immunoglobulin E in the secretory processes of alveolar macrophages from asthmatic patients. J Clin Invest (1983) 1.44
Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am J Respir Crit Care Med (1995) 1.42
Enzyme release and superoxide anion production by human alveolar macrophages stimulated with immunoglobulin E. Clin Exp Immunol (1980) 1.42
Sequential staging systems for small-cell lung cancer. Arch Intern Med (1993) 1.39
Isolated recurrent pleuritis revealing familial mediterranean Fever in adulthood. Respiration (2009) 1.38
Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. The Groupe d'Etudes et de Recherche sur les Maladles "Orphelines" Pulmonaires (GERM"O"P). Am J Respir Crit Care Med (2000) 1.38
[Treatment, by embolization, of severe or repeated hemoptysis associated with systemic hypervascularization]. Nouv Presse Med (1973) 1.37
[Auricular chondritis, malignant glomerulonephritis and pulmonary hemorrhage]. Nephrologie (1991) 1.37
Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells. Eur J Immunol (2001) 1.36
Post-transplant obstructive lung disease ("bronchiolitis obliterans"): a clinical comparative study of bone marrow and lung transplant patients. Eur Respir J (1995) 1.35
Fire-eater's lung: seventeen cases and a review of the literature. Medicine (Baltimore) (2001) 1.34
Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am J Respir Crit Care Med (1998) 1.34
Amyloidosis of the lower respiratory tract. Clinical and pathologic features in a series of 21 patients. Chest (1986) 1.32
Pleural amyloidosis: thoracoscopic aspects. Eur Respir J (1995) 1.30
Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases. J Allergy Clin Immunol (2001) 1.30
Bronchiolitis obliterans organizing pneumonia syndrome primed by radiation therapy to the breast. The Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM"O"P) Am J Respir Crit Care Med (1998) 1.29
Heterogeneity of human eosinophils. II. Variability of respiratory burst activity related to cell density. Clin Exp Immunol (1984) 1.28
Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett (1995) 1.28
Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J Biol Chem (2001) 1.28
Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Eur Respir J (2003) 1.27
Early neutrophil alveolitis after antigen inhalation in hypersensitivity pneumonitis. Chest (1985) 1.25
Th2 polarization by Der p 1--pulsed monocyte-derived dendritic cells is due to the allergic status of the donors. Blood (2001) 1.25
Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1. J Immunol (2001) 1.25
Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore) (2000) 1.23
Self-expandable prostheses in the tracheobronchial tree. Radiology (1993) 1.23
Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J (2003) 1.23
Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma. J Exp Med (1995) 1.22
Apoptosis, proliferation, and expression of Bcl-2, Fas, and Fas ligand in bronchial biopsies from asthmatics. Am J Respir Cell Mol Biol (1998) 1.21
Cytophilic IgE on human blood and tissue eosinophils: detection by flow microfluorometry. J Immunol (1985) 1.18
Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med (1998) 1.16
Mechanisms of fibrosis in coal workers' pneumoconiosis. Increased production of platelet-derived growth factor, insulin-like growth factor type I, and transforming growth factor beta and relationship to disease severity. Am J Respir Crit Care Med (1994) 1.16
Tumor necrosis factor alpha and interleukin-6 production by human mononuclear phagocytes from allergic asthmatics after IgE-dependent stimulation. Am Rev Respir Dis (1992) 1.16
Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin-dependent activation. J Allergy Clin Immunol (1991) 1.15
Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia? Neurology (2005) 1.15
Production of tumor necrosis factor-alpha and interleukin-6 by human alveolar macrophages exposed in vitro to coal mine dust. Am J Respir Cell Mol Biol (1991) 1.12
Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function. Am Rev Respir Dis (1986) 1.11
Increased intestinal permeability in bronchial asthma. J Allergy Clin Immunol (1996) 1.11
Anaphylactic reaction to local administration of rifamycin SV. J Allergy Clin Immunol (1995) 1.11
Cytokines and cytokine network in silicosis and coal workers' pneumoconiosis. Eur Respir J (1995) 1.11
[Endothelin receptor antagonists - their role in pulmonary medicine]. Rev Mal Respir (2009) 1.09
CD28 expression is increased in venom allergic patients but is not modified by specific immunotherapy. Clin Exp Allergy (1996) 1.08
MCP-1 secretion in lung from nonsmoking patients with coal worker's pneumoconiosis. Eur Respir J (1997) 1.07
Secretion of a chemotactic factor for neutrophils and eosinophils by alveolar macrophages from asthmatic patients. J Allergy Clin Immunol (1984) 1.07
Ozone stimulates synthesis of inflammatory cytokines by alveolar macrophages in vitro. Am J Respir Cell Mol Biol (1995) 1.06
Primary pulmonary non-Hodgkin's lymphomas. Histopathology (1995) 1.06
Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a whole. Ann Oncol (1999) 1.06
Expression of E-selectin, ICAM-1 and VCAM-1 on bronchial biopsies from allergic and non-allergic asthmatic patients. Int Arch Allergy Immunol (1995) 1.05
Low levels of the vascular endothelial growth factor in CSF from early ALS patients. Neurology (2004) 1.04
[Treatment of hemoptysis by embolization of the systemic circulation]. Ann Radiol (Paris) (1974) 1.03
New functions for platelets and their pathological implications. Int Arch Allergy Appl Immunol (1985) 1.03
Expression of IL-15 in inflammatory pulmonary diseases. J Allergy Clin Immunol (2001) 1.03
Late pulmonary artery stump thrombosis with post embolic pulmonary hypertension after pneumonectomy. Thorax (2006) 1.02
Thiol regulation of the production of TNF-alpha, IL-6 and IL-8 by human alveolar macrophages. Eur Respir J (1999) 1.01
Herniation of the left atrial appendage through a congenital partial pericardial defect. Eur Heart J (1991) 1.01
Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study. Rheumatology (Oxford) (2001) 1.00
Expression and functions of the high-affinity IgE receptor on human platelets and megakaryocyte precursors. Eur J Immunol (1997) 1.00
In vitro acute effects of tobacco smoke on tumor necrosis factor alpha and interleukin-6 production by alveolar macrophages. Exp Lung Res (1993) 1.00
Evidence of lymphocyte alveolitis in Crohn's disease. Chest (1985) 1.00
Primary biliary cirrhosis. Subclinical inflammatory alveolitis in patients with normal chest roentgenograms. Chest (1986) 0.99
Levels of soluble IL-2 receptor in plasma from asthmatics. Correlations with blood eosinophilia, lung function, and corticosteroid therapy. Clin Exp Immunol (1992) 0.99
Histamine induces interleukin-8 secretion by endothelial cells. Blood (1994) 0.99
Inhibition by nedocromil sodium of IgE-mediated activation of human mononuclear phagocytes and platelets in allergy. Int Arch Allergy Appl Immunol (1988) 0.99
MR diagnosis of lipoid pneumonia. J Comput Assist Tomogr (1988) 0.98
Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus. Am J Respir Crit Care Med (1999) 0.97
Churg-Strauss syndrome. Allergy (1999) 0.97
Quality of life in nasal polyposis. J Allergy Clin Immunol (1999) 0.96
Subclinical alveolitis in immunological systemic disorders. Transition between health and disease? Eur Respir J (1990) 0.96
Aspirin-sensitive asthma: abnormal platelet response to drugs inducing asthmatic attacks. Diagnostic and physiopathological implications. Int Arch Allergy Appl Immunol (1985) 0.96
Chronic eosinophilic pneumonia after radiation therapy for breast cancer. Eur Respir J (2004) 0.95
Histamine induces IL-6 production by human endothelial cells. Clin Exp Immunol (1994) 0.95
[Idiopathic chronic eosinophilic pneumonia]. Rev Mal Respir (2006) 0.95
Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X). Groupe d'Etude en Pathologie Interstitielle de la Société de Pathologie Thoracique du Nord. Eur Respir J (1996) 0.95
Production of chemokines and proinflammatory and antiinflammatory cytokines by human alveolar macrophages activated by IgE receptors. J Allergy Clin Immunol (1999) 0.95
Transforming growth factor-beta1 in sarcoidosis. Eur Respir J (1998) 0.95